Emily Leproust

Emily Leproust



 

Overview

As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases, and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.

Twist Biosciences

To greatly accelerate the development of personalized ...

CEO

- Present


Explore

Revision History

Last Update: Nov 30, 2017 12:00 a.m.

Incoming

Twitter


Tags



COPYRIGHT 2024 IMPACTSPACE. ALL RIGHTS RESERVED.